FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Knowing when to prioritize financial planning over investment planning can significantly impact your financial success. Find the right balance for your goals.
25,635 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Microsoft led a rebound among the Magnificent 7 as investors rotated back into software, while Apple and Alphabet sli...
BYD could shift from a large EV maker to a vertically integrated electrification leader. This piece lays out the thre...
Oracle posted stronger-than-expected cloud results for Q3 FY2026, sending ORCL higher and helping the stock lead tech...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
Oil prices slid more than 5% on Monday as Washington urged allies to join a broader effort to safeguard the Strait of...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
Figuring out what considered good stock dividends means looking beyond yield. This article breaks down the metrics th...
A Goldman Sachs trading desk note argues that heavy institutional deleveraging has run its course, suggesting a poten...
Ibotta's Q1 2026 earnings reveal a company balancing rapid user growth with a longer road to sustainable profitabilit...
In May, a calmer approach can shine. This article highlights two dividend stocks that are no-brainer buys for conserv...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...